Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Reference standard methodology in the clinical evaluation of AI chest X-ray algorithms for lung cancer detection: A systematic review
1
Zitationen
9
Autoren
2025
Jahr
Abstract
BACKGROUND: Lung cancer remains the leading cause of cancer death worldwide, with early diagnosis linked to improved survival. Artificial intelligence (AI) holds promise for augmenting radiologists' workflows in chest X-ray (CXR) interpretation, particularly for detecting thoracic malignancies. However, clinical implementation of this technology relies on robust and standardised reference standard methodology at the patient-level. PURPOSE: This systematic review aims to describe reference standard methodology in the clinical evaluation of CXR algorithms for lung cancer detection. MATERIALS AND METHODS: Searches targeted studies on AI CXR analysis across MEDLINE, Embase, CENTRAL, and trial registries. 2 reviewers independently screened titles and abstracts, with disagreements resolved by a 3rd reviewer. Studies lacking external validation in real-world cohorts were excluded. Bias was assessed using a modified QUADAS-2 tool, and data synthesis followed SWiM guidelines. RESULTS: 1,679 papers were screened with 46 papers included for full paper review. 24 different AI solutions were evaluated across a broad range of research questions. We identified significant heterogeneity in reference standard methodology, including variations in target abnormalities, reference standard modality, expert panel composition, and arbitration techniques. 25 % of reference standard parameters were inadequately reported. 66 % of included studies demonstrated high risk of bias in at least one domain. DISCUSSION: To our knowledge, this is the first systematic description of patient-level reference standard methodology in CXR AI analysis of thoracic malignancy. To facilitate translational progress in this field, researchers undertaking evaluations of diagnostic algorithms at the patient-level should ensure that reference standards are aligned with clinical workflows and adhere to reporting guidelines. Limitations include a lack of prospective studies.
Ähnliche Arbeiten
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 · 15.813 Zit.
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 · 11.473 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.878 Zit.
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 · 9.995 Zit.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
2015 · 9.415 Zit.